Cardiovascular Systems
Saint Paul · Founded 1989
About Cardiovascular Systems
Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Their primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications. Cardiovascular Systems develop solutions for the treatment of peripheral and coronary artery disease, to help physicians conquer calcium, one of the largest challenges when treating PAD and CAD.
Company Facts
- Founded: 1989
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $98.0M
- Funding stage: M&A
- Last round: Post-IPO Debt (Mar 2013)
- Ticker: nasdaq:CSII
- Website: csi360.com
- Phone: 6512591696
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cardiovascular-systems-2430868 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.